CeGaT

Tubingen, Germany Founded: 2002 • Age: 24 yrs
Provider of drug research and development services to develop genetic causes of rare diseases
Request Access

About CeGaT

CeGaT is a company based in Tubingen (Germany) founded in 2002.. The company has 113 employees as of December 31, 2020. CeGaT offers products and services including Exome Diagnostics, Prenatal ExomeXtra, Panel Diagnostics, and CancerPrecision. CeGaT operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Omniome, Ipsen and Tessera Therapeutics, among others.

  • Headquarter Tubingen, Germany
  • Employees 113 as on 31 Dec, 2020
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Cegat Gmbh
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $108.6 K (USD), Grant

    Jan 01, 2016

  • Investors
  • Employee Count
    113

    as on Dec 31, 2020

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of CeGaT

CeGaT offers a comprehensive portfolio of products and services, including Exome Diagnostics, Prenatal ExomeXtra, Panel Diagnostics, and CancerPrecision. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Service for detecting genetic variants in rare diseases

Sequencing tool for prenatal genetic analysis

Targeted sequencing for specific disease panels

Tool for precise tumor genetic analysis

People of CeGaT
Headcount 200-500
Employee Profiles 24
Employee Profiles
People
Dirk Biskup
Managing Director
People
Saskia Biskup
Managing Director
People
Florian Battke
Director, Development
People
Jiri Ködding
Director, Operations

Unlock access to complete

Funding Insights of CeGaT

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $108,600
  • First Round

    (01 Jan 2016)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2016 Amount Grant - CeGaT Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in CeGaT

CeGaT has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by CeGaT

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - CeGaT

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cegat Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of CeGaT

CeGaT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Omniome, Ipsen and Tessera Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Laboratory testing and contract research services are provided globally.
domain founded_year HQ Location
Provider of CRO and CDMO services
domain founded_year HQ Location
Genome sequencing platform is provided for clinical diagnostics.
domain founded_year HQ Location
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
domain founded_year HQ Location
New genome engineering technology is provided for treating multiple diseases.
domain founded_year HQ Location
DNA-encoded libraries are developed for drug discovery applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cegat

Frequently Asked Questions about CeGaT

When was CeGaT founded?

CeGaT was founded in 2002 and raised its 1st funding round 14 years after it was founded.

Where is CeGaT located?

CeGaT is headquartered in Tubingen, Germany. It is registered at Tubingen, Baden-wurttemberg, Germany.

How many employees does CeGaT have?

As of Dec 31, 2020, the latest employee count at CeGaT is 113.

What does CeGaT do?

CeGaT, founded in 2002 in Tubingen, Germany, focuses on providing healthcare solutions, biopharma outsourcing, and diversified. Provider of drug research and development services to develop genetic causes of rare diseases. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Who are the top competitors of CeGaT?

CeGaT's top competitors include Tessera Therapeutics, Novogene Corporation and WuXi AppTec.

What products or services does CeGaT offer?

CeGaT offers Exome Diagnostics, Prenatal ExomeXtra, Panel Diagnostics, and CancerPrecision.

Who are CeGaT's investors?

CeGaT has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available